SK99298A3 - 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system - Google Patents

1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system Download PDF

Info

Publication number
SK99298A3
SK99298A3 SK992-98A SK99298A SK99298A3 SK 99298 A3 SK99298 A3 SK 99298A3 SK 99298 A SK99298 A SK 99298A SK 99298 A3 SK99298 A3 SK 99298A3
Authority
SK
Slovakia
Prior art keywords
formula
ethyl
methyl
pyrazolyl
indole
Prior art date
Application number
SK992-98A
Other languages
English (en)
Slovak (sk)
Inventor
Henning Bottcher
Joachim Marz
Gerd Bartoszyk
Hartmut Greiner
Jurgen Harting
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK99298A3 publication Critical patent/SK99298A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK992-98A 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system SK99298A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602505A DE19602505A1 (de) 1996-01-25 1996-01-25 1-(Pyrazol-4-Indol-3-yl)-Piperidine
PCT/EP1997/000187 WO1997027186A1 (de) 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine als das zentralnervensystem beeinflussende mittel

Publications (1)

Publication Number Publication Date
SK99298A3 true SK99298A3 (en) 1999-01-11

Family

ID=7783568

Family Applications (1)

Application Number Title Priority Date Filing Date
SK992-98A SK99298A3 (en) 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system

Country Status (16)

Country Link
EP (1) EP0879234A1 (hu)
JP (1) JP2000503972A (hu)
KR (1) KR19990081970A (hu)
CN (1) CN1209807A (hu)
AR (1) AR005549A1 (hu)
AU (1) AU715785B2 (hu)
BR (1) BR9707467A (hu)
CA (1) CA2244136A1 (hu)
CZ (1) CZ231898A3 (hu)
DE (1) DE19602505A1 (hu)
HU (1) HUP9900980A2 (hu)
NO (1) NO983439L (hu)
PL (1) PL328228A1 (hu)
SK (1) SK99298A3 (hu)
WO (1) WO1997027186A1 (hu)
ZA (1) ZA97572B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509509A (ja) * 1999-09-09 2003-03-11 ハー・ルンドベック・アクチエゼルスカベット 5−アミノアルキル及び5−アミノカルボニル置換されたインドール類
PL356487A1 (en) 1999-11-10 2004-06-28 Takeda Chemical Industries, Ltd. 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
AU2001281255B2 (en) 2000-08-14 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
HUP0402124A2 (hu) * 2001-11-14 2005-02-28 Merck Patent Gmbh Pszichofarmakológiában alkalmazható pirazolszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BRPI0617204A2 (pt) 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
JP2009515833A (ja) * 2005-10-24 2009-04-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 3−ピペリジン−4−イル−インドールorl−1受容体モジュレーター
TWI548630B (zh) * 2011-04-06 2016-09-11 Lg生命科學有限公司 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶型及其製造方法
TW202336015A (zh) * 2020-11-04 2023-09-16 南韓商Lg化學股份有限公司 唑-4-羧酸結晶之製備方法及包含彼之醫藥組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060816C3 (de) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
DE2258033A1 (de) * 1972-11-27 1974-05-30 Merck Patent Gmbh Verfahren zur herstellung von pyrazolderivaten
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
US5045550A (en) * 1990-09-20 1991-09-03 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine

Also Published As

Publication number Publication date
CZ231898A3 (cs) 1998-10-14
WO1997027186A1 (de) 1997-07-31
CA2244136A1 (en) 1997-07-31
EP0879234A1 (de) 1998-11-25
CN1209807A (zh) 1999-03-03
NO983439L (no) 1998-09-25
AU1443297A (en) 1997-08-20
DE19602505A1 (de) 1997-07-31
NO983439D0 (no) 1998-07-24
BR9707467A (pt) 1999-07-20
AU715785B2 (en) 2000-02-10
ZA97572B (en) 1997-08-04
JP2000503972A (ja) 2000-04-04
HUP9900980A2 (hu) 1999-07-28
AR005549A1 (es) 1999-06-23
PL328228A1 (en) 1999-01-18
KR19990081970A (ko) 1999-11-15

Similar Documents

Publication Publication Date Title
RU2132848C1 (ru) Производные пиперидина и пиперазина, способ их получения, содержащие их фармацевтические композиции и способ их получения
SK135595A3 (en) Benzylpiperidine derivative, preparation method and pharmaceutical composition containing the same
SK280881B6 (sk) Derivát 3-indolylpiperidínu, spôsob jeho prípravy, jeho použitie na prípravu farmaceutického prostriedku a farmaceutický prostriedok, ktorý ho obsahuje
SK13692000A3 (sk) Derivát 1-(3-heteroarylpropyl- alebo -prop-2-enyl)-4-benzylpiperidínu ako antagonistu nmda receptora, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
FR2667068A1 (fr) Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5266570A (en) Piperidine derivatives, compositions and use
JPH01265100A (ja) 2―置換アデノシン誘導体
SK141998A3 (en) Piperidines and pyrrolidines
SK99298A3 (en) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system
AU772978B2 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
CA2128380C (en) 4-aryloxy- and 4-arylthiopiperidine derivatives
JPH0699420B2 (ja) 水素添加された1−ベンゾオキサシクロアルキルピリジンカルボン酸化合物,その製造方法及び該化合物を含む医薬製剤
RU2156249C2 (ru) Соединения фенилиндола
SK136895A3 (en) Oxazoleidinone derivative, preparing method and pharmaceutical composition containing it
EP0315405A1 (en) 4-phenyl-4-(N-(2-fluorophenyl)amido) piperidine derivatives
RU2175970C2 (ru) Производные пиперидинилметилоксазолидин-2-она, способ их получения и фармацевтическая композиция на их основе
CZ42996A3 (en) Oxazolidinone derivative, process of its preparation and pharmaceutical preparation containing thereof
MXPA96003567A (es) Derivados de la piperidinilmetiloxazolidin-2-ona
HUT70557A (en) N,n'-disubstituted amine derivative, pharmaceutical compositions containing them and process for producing the compounds and the compositions
DK168953B1 (da) 5- eller 6-benzyloxysubstituerede beta-carbolin-3-carboxylsyreestere samt fremgangsmåde til fremstilling heraf
EP0602458A1 (en) 1,4-Benzoxazine derivatives
FR2639944A1 (fr) Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6228870B1 (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
AU3126200A (en) Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
JP2000007671A (ja) 2,3−ジヒドロベンゾフラン誘導体